Hyun Chul Jung

Fondateur chez Beijing Sainuotai Biotechnology Co. Ltd.

Fortune : 19 M $ au 30/04/2024

62 ans

Health Technology

Consumer Services

Postes actifs de Hyun Chul Jung

Sociétés	Poste	Début	Fin
Immunotech Applied Science Ltd.	Directeur/Membre du Conseil	01/11/2006	-
Beijing Sainuotai Biotechnology Co. Ltd.	Directeur/Membre du Conseil	-	-
	Directeur Général	-	-
	Fondateur	-	-

Sociétés	Poste	Début	Fin
IMMUNOTECH BIOPHARM LTD	Directeur/Membre du Conseil	23/08/2019	24/03/2023
IMMUNOTECH BIOPHARM LTD	Corporate Officer/Principal	23/08/2019	24/03/2023
Pharos Vaccine, Inc. Pharos Vaccine, Inc. BiotechnologyHealth Technology Pharos Vaccine, Inc. engages in research, development, and production of bio medicines such as vaccines and immune therapeutics. The company was founded on April 8, 2011 and is headquartered in Seongnam, South Korea.	Directeur/Membre du Conseil	01/04/2011	01/03/2019
	Directeur Général	01/04/2011	01/03/2019

Yonsei University

Graduate Degree

Internationale

Opérationnelle

Director/Board Member	4
Chief Executive Officer	2
Corporate Officer/Principal	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
IMMUNOTECH BIOPHARM LTD	Health Technology

Entreprise privées	3
Pharos Vaccine, Inc. Pharos Vaccine, Inc. BiotechnologyHealth Technology Pharos Vaccine, Inc. engages in research, development, and production of bio medicines such as vaccines and immune therapeutics. The company was founded on April 8, 2011 and is headquartered in Seongnam, South Korea.	Health Technology
Immunotech Applied Science Ltd.
Beijing Sainuotai Biotechnology Co. Ltd.